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The Importance of Asking “How and Why?” in Natural Product 
Structure Elucidation 
Patrick D. Brown and Andrew L. Lawrence* 
This review highlights why careful consideration of the biosynthetic origin (the how) and the biological function (the why) 
of a natural product can be so useful during the determination of its structure. Recent examples of structural 
reassignments inspired by biosynthetic and functional insights will be presented. This review will demonstrate the 
importance of viewing the origin, structure and function of a natural product as intertwined threads of a single story, best 
viewed as a whole rather than as discrete topics. 
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1 Introduction 
Despite the power of modern spectroscopy, the structural 
elucidation of complex natural products is still a very difficult 
undertaking.1 This can be further compounded by a variety of 
issues: lack of sufficient material; difficulties in purification; a 
particularly challenging or unusual aspect of structural 
complexity; and human errors, which can occur all too easily 
when dealing with such complex data sets. Thankfully, other 
tools are available to chemists in their quest for certainty 
during structure elucidations. Total synthesis is a very robust 
method for the confirmation or reassignment of natural 
product structures, with excellent reviews concerning this 
topic already available.2 It is also clear that computational 
techniques for predicting and modeling spectroscopic data are 
emerging as very powerful tools, with relevant reviews again 
already available.3 This mini-review will highlight the often 
underappreciated power of simply considering the 
biosynthetic origin of a natural product when determining its 
structure.4 This involves no new equipment or expensive 
materials, it is not overly time-consuming, and can often 
provide added benefits to any associated synthetic efforts or 
functional investigations.5 The emerging, albeit currently 
limited, role of functional considerations during structure 
elucidations will also be highlighted. 
When faced with a natural product it is prudent to carefully 
consider how and why it exists. This will typically include some, 
or all, of the following steps:  
 
1) Identification of likely biosynthetic building blocks. 
2) Proposal of feasible metabolic pathways. 
3) Direct comparison to biosynthetically related structures. 
4) Consideration of any known or proposed functional roles. 
 
If nothing else, these relatively straightforward steps can 
serve as a reassuring check that any proposed structure, 
particularly if novel, makes logical sense. Obviously, this type 
of thought process does not provide hard evidence regarding a 
proposed structure, but it often leads to important insights 
and realizations. Then, if warranted, biomimetic synthetic 
studies or direct biosynthetic studies can be undertaken to 
probe the structure and origin of the natural product(s) 
further. 
2 Case Studies 
This review is not intended to be exhaustive; instead, a limited 
number of examples will be used to illustrate some guiding 
ARTICLE Journal Name 
2 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
principles. Firstly, the reassignment of the cytosporolides by 
George and Spence typifies how recognition of biosynthetically 
improbable structural features can lead to successful 
reassignments (Section 2.1). The process of deconstructing a 
natural product into its constituent metabolic building blocks is 
showcased in the reassignment of incargranine B (Section 2.2). 
Placement of a structure within its wider natural product 
family, thus revealing inconsistencies, is seen in Brill and 
Snyder’s reassignment of the caraphenols (Section 2.3). The 
serendipitous reassignment of natural products during 
biomimetic syntheses is showcased in Calvert and Sperry’s 
total synthesis of yuremamine (Section 2.4). Thomson’s work 
on the cyclic prodigiosins is presented to illustrate how 
consideration of the function of a natural product can be used 
to successfully interrogate proposed structures (Section 2.5). 
Finally, reassignment of the tridachiahydropyrones by Moses 
and co-workers brings many of these principles together in a 
single case study (Section 2.6). 
 
2.1 Cytosporolides A-C 
 
Figure 1. The originally proposed and revised structure of 
cytosporolide A. 
 
The cytosporolides (e.g., cytosporolide A, see Figure 1) are 
caryophyllene-derived meroterpenoids isolated in 2010 by Che 
and colleagues from the fungus Cytospora sp.6 The carbon 
framework and oxygenation pattern of the caryophyllene-
derived moiety was assigned using 1D and 2D NMR 
spectroscopy, assisted by comparison to the NMR data of 
known natural products 6-hydroxpunctaporonin B (2)7 and, the 
co-isolated, fuscoatrol A (3) (Figure 2).8 On the basis of the 
downfield chemical shift of C(8) in cytosporolide A (1a) (87.5 
ppm), compared to the analogous hydroxylated C(8) position 
of 6-hydroxypunctaporonin B (2) (74.2 ppm), Che and 
coworkers proposed that the cytosporolides contained an 
unusual 9-membered peroxylactone ring (Figure 2).6 
 
Figure 2. Che’s proposed structure for cytosporolide A 
alongside known natural products used to assist the structural 
assignment. 
 
The presence of this unusual and highly strained structural 
feature led George and Spence to further investigate the 
reported characterization data.9 Comparison of the key C(8) 
chemical shift in cytosporolide A to the C(8) positions of the 
caryophyllene-derived natural products guajadial (4) (84.3 
ppm)10 and psidial A (5) (88.0 ppm)11 suggested that a similar 
6-membered aryl ether ring could account for the observed 13C 
NMR data (Scheme 1a). George speculated that a biosynthetic 
pathway analogous to that proposed by Lee for guajadial (4) 
and psidial A (5) (see Scheme 1a)12 could produce an 
alternative structure for cytosporolide A (1b), which might 
adequately account for the reported characterization data. 
Thus, a [4+2] cycloaddition between fuscoatrol A (3) and an 
ortho-quinone methide (6), derived from the known fungal 
metabolite CJ-12,373,13 would give structure 1b (Scheme 1b). 
 To test this biosynthetic hypothesis and structural revision, 
George and Spence conducted a biomimetic model study to 
produce the core framework of their proposed cytosporolide 
structure 1b.9 β-caryophyllene 8 was added to model ortho-
quinone methide 7 and heating to 100°C gave Diels–Alder 
adduct 9 in 53% yield as a single diastereomer (Scheme 1c). 
The structure of model compound 9 was confirmed by single 
crystal X-ray analysis and despite having opposite 
stereochemical configurations to the cytosporolides (e.g., 1b) 
at C(8), C(9) and C(16), the NMR and IR spectra of adduct 9 
were found to be very similar to those reported for 
cytosporolides A-C. In particular, the key C(8) resonance in the 
model compound 9 occurred at 88.6 ppm, closely matching 
the cytosporolide A C(8) signal (88.0 ppm). George’s proposed 
structural revision of cytosporolide A (1b) was subsequently 
confirmed by Takao and co-workers, in their 2015 total 
synthesis of cytosporolide A (1b),14 which followed a strategy 
analogous to George’s biosynthetic hypothesis (Scheme 1b).9 
Takao’s total synthesis provides unequivocal validation of 
George’s proposed structural reassignment and postulated 
biosynthesis. 
 
Scheme 1. a) Previously proposed biosynthesis of guajadial 
and psidial A. b) George's biosynthetic proposal and proposed 
structural revision for cytosporolide A. c) George's model 
biomimetic study. 
 
2.2 Incargranine B 
 
Figure 3. The originally proposed and revised structure of 
incargranine B. 
 
Incargranine B was isolated from Incarvillea mairei var. 
grandiflora in 2010 by Zhang and co-workers (Figure 3).15 HR-
ESI-MS revealed the molecular formula to be C36H50N2O12 and 
analysis of the 1D NMR data revealed the presence of two 
phenylethanoid units and two β-glucopyranose units. 
Extensive analysis of the 2D NMR data led Zhang and co-
workers to propose a novel indolo[1.7]napthyridine alkaloid 
structure for incargranine B (10a). 
Incargranine B formulates as a dimer, containing two 
shikimate-derived C6C2 units, two ornithine-derived C4N units 
and two glucose units (Scheme 2a). Consideration of the 
biosynthetic origins of this previously unknown 
indolo[1.7]napthyridine framework 10a, however, led us to 
question the validity of this structural proposal. It should be 
stressed that our analysis of the available spectroscopic data 
did not lead us to question Zhang’s proposal. Ostensibly, the 
proposed structure 10a did fit with the spectroscopic data 
reported for incargranine B,15 and it was only our biosynthetic 
considerations that revealed a problem may exist. Specifically, 
any potential biosynthesis of indolo[1.7]napthyridine 10a, 
involving ornithine-derived building blocks, would necessitate 
the cleavage and formation of an unusually high number of 
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bonds. This biosynthetic puzzle led us to speculate that a more 
biosynthetically plausible dipyrroloquinoline structure 10b 
could account for the characterization data reported for 
incargranine B (Figure 3).16 
We proposed phenylethanoid-diamine 11 represented a 
reasonable biosynthetic precursor to incargranine B (Scheme 
2b). Oxidative deamination of diamine 11 could give an 
aldehyde 12, which, following intramolecular condensation, 
would give an N-aryl enamine 13. Enamine 13 could then 
dimerize with its corresponding iminium ion 14, via a domino 
Mannich/SEAr (electrophilic aromatic substitution) reaction 
sequence (i.e., a Povarov reaction), to give our proposed 
alternative structure for incargranine B (10b).17 
 
Scheme 2. a) Our attempted retro-biosynthetic analysis of 
Zhang's proposed structure for incargranine B. b) Biosynthetic 
speculation and newly proposed structure for incargranine B. 
c) Biomimetic synthesis and structural revision of incargranine 
B. 
 
To test both our proposed structural revision and new 
biosynthetic speculation, we undertook a short biomimetic 
synthesis of incargranine B (Scheme 2c).16 The acetal protected 
cyclisation precursor 15 (prepared in 3 steps) was exposed to 
2M aqueous HCl to deprotect the aldehyde and induce the 
condensation/Mannich/SEAr reaction sequence, giving a 
mixture of two dimeric products 16 and 17, in 50% isolated 
yield. Analysis of the 1H and 13C NMR spectra for the minor 
product, 17, revealed key similarities with the NMR data 
reported for incargranine B. Thus, dimer 17 was doubly 
glycosylated before global deprotection afforded the target 
structure 10b, as the expected 1:1 mixture of diastereomers (a 
result of glycosidation of a racemic aglycone). Data for this 
mixture of diastereomers, including optical rotation, matched 
extremely well with that reported for the natural product. 
Thus it is likely that natural incargranine B also exists as a 
mixture of diastereomers. Our proposed structural revision 
was, therefore, shown to be correct and the chemical 
feasibility of the biosynthetic hypothesis had been 
demonstrated. 
 
2.3 Caraphenols B and C 
 
Figure 4. The originally proposed and revised structures of 
caraphenol B & C. 
 
Caraphenols B and C are resveratrol dimers, originally isolated 
from the roots of Caragana sinica by Hu and co-workers in 
2001 (Figure 4).18 On the basis of HRMS, UV-Vis and NMR data, 
Hu proposed substituted indane structures for caraphenol B 
(19a) and C (20a), differing in the hydroxylation pattern of the 
B and C-rings. Hu proposed relative stereochemistry featuring 
an all cis arrangement of the B, C and D-rings based on NOESY 
experiments.18 
This all cis arrangement, which is highly unusual within the 
wider family of resveratrol-derived indane natural products (cf. 
natural products 21-24, see Figure 5),20-23 prompted Brill and 
Snyder to further investigate the structures of caraphenol B 
and C.19 They speculated that alternative structures with 
trans,trans stereochemistry (19b and 20b) could adequately 
account for all the spectroscopic data reported for caraphenol 
B and C (Figure 4).19 
 
Figure 5. Known resveratrol-derived indane natural products. 
 
To test this hypothesis, Snyder and Brill set about 
preparing samples of both Hu’s (19a, 20a) and their own (19b, 
20b) proposed structures for caraphenols B and C. Hu’s 
structure for caraphenol B (19a) was prepared in five steps 
from permethylated ampelopsin D (25) (Scheme 3a). X-ray 
analysis of a derivative of synthetic 19a confirmed the 
anticipated all cis stereochemistry. Analysis of the NMR data 
for synthetic 19a showed significant discrepancies to that 
reported for caraphenol B.19 
 
Scheme 3. a) Snyder’s synthesis of Hu’s proposed caraphenol B 
structure. b) Snyder’s total synthesis and structural revision of 
caraphenol B. 
 
Snyder’s proposed trans,trans structure (19b) was 
accessed in seven steps from permethylated paucifloral F (26) 
(Scheme 3b), via formation of the trans,cis compound 27, 
which was epimerized to the desired trans,trans diastereomer 
prior to global deprotection to give caraphenol B (19b). Similar 
synthetic sequences allowed access to the original and newly 
proposed structures for caraphenol C (20a and 20b). In both 
cases the newly proposed structures (19b, 20b) matched the 
reported data for the natural products in all respects, allowing 
Snyder and Brill to confirm their proposed structural 
revisions.19 This revision of natural product stereochemistry 
highlights how conserved structural features within a family of 
biosynthetically related natural products (i.e., configuration of 
the core motif) can help identify potentially anomalous 
structures. 
 
2.4 Yuremamine 
 
Figure 6. The originally proposed and revised structures of 
yuremamine. 
 
Yuremamine was isolated in 2005 by Callaway and co-
workers from the bark of Mimosa tenuiflora, a plant used in 
Brazil to prepare a psychoactive beverage. Callaway and co-
workers proposed a pyrroloindole structure 28a, which has an 
intramolecular hydrogen bond. It was proposed that this 
hydrogen bond could protect yuremamine from monoamine 
oxidase metabolism, which could cause inhibition of the 
enzyme and facilitate the oral bioavailability of the N,N-
dimethyltryptamine also present in the bark (Figure 6).24 
 
Scheme 4. Sperry’s proposed biosynthetic pathway for the 
originally proposed yuremamine structure. 
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Calvert and Sperry proposed a biosynthetic pathway 
towards yuremamine (28a) featuring an initial 
diastereoselective coupling of the known natural product, 
leucorobinetinidin (29)26 with N,N-dimethyltryptamine to give 
the flavonoid indole 28b.25 Photochemically induced cleavage 
of the benzylic C−O bond could then give the para-quinone 
methide 30 which could be trapped via [1,6]-addition of the 
indole nitrogen to give yuremamine (28a) (Scheme 4). 
 
Scheme 5. Sperry and Calvert’s synthesis and reassignment of 
yuremamine. 
 
Based on this biosynthetic hypothesis, Calvert and Sperry 
undertook a short biomimetic synthesis, initially of the 
flavonoid indole 28b, which they hoped to subsequently 
rearrange to give the proposed structure of yuremamine (28a) 
(Scheme 5). They successfully accessed the key protected 
leucorobinetinidin analogue 31 in three steps from 
acetophenone 32 and aldehyde 33 in 32% yield. They were 
then able to diastereoselectively couple diol 31 with N,N-
dimethyltryptamine in the presence of TMSOTf, followed by a 
global deprotection to give the postulated key biosynthetic 
intermediate 28b in a 56% yield over the two steps (Scheme 
5).25 Intriguingly, the NMR data for this proposed biosynthetic 
intermediate 28b was found to be very similar to that reported 
for the natural product. On conversion to the TFA salt, which is 
how natural yuremamine was characterized, the spectroscopic 
data for this postulated intermediate 28b was found to match 
perfectly with that reported for the natural product.25 The 
possibility that the material had spontaneously rearranged to 
give 28a was ruled out by detailed analysis of 2D NMR data 
and the observation of an indole NH signal in the 1H-15N HSQC 
spectrum. Thus, Calvert and Sperry were able to conclusively 
reassign the natural product structure to that of their 
proposed biosynthetic intermediate 28b. This was further 
verified by Iwasawa and co-workers who synthesized the 
originally proposed structure of yuremamine 28a, plus all 
other diastereomers, and confirmed they all differ from the 
natural product.27 Calvert and Sperry’s serendipitous discovery 
provides a striking example of the benefits of pursuing 
biomimetic strategies in total synthesis. 
 
2.5 Streptorubin B/Butylcycloheptylprodigiosin 
 
Figure 7. The proposed structures of 
butylcycloheptylprodigiosin and streptorubin B. 
 
In 1975 Gerber reported the isolation of a cyclic prodigiosin 
natural product from the bacteria Streptomysces sp. Y-42 and 
S. rubrireticuli.28 An ortho-annulated structure 34a was 
proposed for this metabolite (Figure 7), which was named 
butylcycloheptylprodigiosin.28 This structure was assigned 
based on analysis of MS, UV-Vis and limited NMR data; GC 
analysis of oxidative degradation products; and by comparison 
to the known prodigiosin natural products undecylprodigiosin 
(35) and metacycloprodigiosin (36) (Scheme 6). Gerber later 
concluded, however, that this originally assigned structure 34a 
was incorrect, identifying that the isolated material was the 
known natural product streptorubin B, which has a meta-
annulated structure 34b (Figure 7).29 Evidence, from other 
groups, however, was subsequently presented which 
supported butylcycloheptylprodigiosin (34a) as a distinct 
natural product from streptorubin B (34b). Floss reported the 
isolation of a pink pigment from Streptomyces coelicolor A3(2) 
in 1985 and assigned it as butylcycloheptylprodigiosin (34a).30 
Furthermore, Fürstner and co-workers completed a total 
synthesis of butylcycloheptylprodigiosin (34a) in 2005 and, 
based on comparison to a sample of Floss’ natural product 
(which was not pure), concluded it was a true natural 
product.31 However, in 2008 Challis, Reynolds and co-workers 
reported extensive NMR analyses that conclusively 
demonstrated that the carbocyclic derivative of 
undecylprodigiosin produced by Streptomyces coelicolor M511 
(a derivative of the original A3(2) strain used by Floss) was 
streptorubin B, not butylcycloheptylprodigiosin.32a 
An ongoing interest in the synthesis and biosynthesis of 
cyclic prodigiosins, led Thomson and co-workers to also re-
examine the proposed structure of butylcycloheptylprodigiosin 
(34a).32 Thomson noted that several carbocyclic prodigiosin 
derivatives are biosynthesized from a common precursor, 
undecylprodigiosin (35), via oxidative cyclization processes 
exclusively to C(4) of the C-ring pyrrole, or to C(5) of the A-ring 
pyrrole (e.g., metacycloprodigiosin (36) and 
methylcyclodecylprodigiosin (37), see Scheme 6).33 This highly 
conserved cyclisation pattern within the cyclic prodigiosin 
family led Thomson to speculate that cyclisation to these 
positions must provide an evolutionarily important function. 
They suggested that these cyclisation patterns provide a 
conformational bias between the A, B and C pyrrole rings, 
which allows for effective ion binding (Scheme 6). The unusual 
cyclisation to C(4) of the C-ring pyrrole in 
butylcycloheptylprodigiosin (34a) would not provide the same 
conformational bias, removing this presumed evolutionary 
function.32 
 
Scheme 6. Other known cyclic prodigiosin natural products, 
which are biosynthetically derived from undecylprodigiosin, 
and Thomson’s proposed ion-binding model. 
 
Thomson and co-workers, re-synthesized the proposed 
butylcycloheptylprodigiosin structure 34a and compared this 
synthetic material to previously reported data for synthetic 
butylcycloheptylprodigiosin (34a) and the natural product 
isolated by Floss and co-workers.32 Although the NMR data for 
their synthetic material matched well with previously reported 
synthetic material, they found discrepancies to the data 
reported for the naturally occurring compound, which they 
were not able to resolve using NMR spectroscopy. As a result, 
they turned to a comparison of the EI mass spectra. From this 
they found that synthetic butylcycloheptylprodigiosin (34a) 
and synthetic streptorubin B (34b)34 showed characteristic 
differences in their EI mass spectra, with the data attributed to 
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natural butylcycloheptylprodigiosin matching the mass 
spectrum of synthetic streptorubin B (34b) extremely well. On 
this basis, they concluded that butylcycloheptylprodigiosin 
(34a) was unlikely to represent a genuine natural product.32 
Thomson’s confirmation that butylcycloheptylprodigiosin (34a) 
is not a natural product provides a clear example of how 
consideration of the biological function of a compound can 
further highlight possible discrepancies in structural 
assignments.35 As the quantity and quality of available 
functional information increases we predict this will become 
an increasingly useful consideration for structure 
determinations. 
 
2.6 Tridachiahydropyrones 
 
Figure 8. The originally proposed and revised structures of the 
tridachiahydropyrones. 
 
The tridachiahydropyrones are polyketide-derived pyrone 
natural products isolated from sacoglossan molluscs. 
Tridachiahydropyrone was isolated by Cimino and co-workers 
in 1996 from Tridachia crispata and assigned structure 38a on 
the basis of HRMS, 1D and 2D NMR data (Figure 8).36 
Tridachiahydropyrones B (39a) and C (40a) were isolated from 
another sacoglossan mollusc, Placobranchus ocellatus, by 
Schmitz and co-workers in 2000 as an inseparable 4:5 mixture 
(Figure 8).37 Using HRMS, 1D and 2D NMR, IR and UV-Vis 
spectroscopy, Schmitz and co-workers were able to assign the 
connectivity of tridachiahydropyrones B (39a) and C (40a). 
Schmitz noted the close structural similarity to 
tridachiahydropyrone (38a) and suggested that the 
inseparable mixture of tridachiahydropyrones B (39a) and C 
(40a) was due to differing geometry around the C(10)–C(11) 
alkene; however, full assignment of the relative 
stereochemistry was not possible.37 
The sacoglossan molluscs have long been a source of great 
interest to chemists, providing a range of intriguing pyrone 
natural products. Previous biosynthetic and biomimetic studies 
by Faulkner, Ireland, Clardy and Solheim had demonstrated 
that many γ-pyrone natural products from Tridachiella and 
Tridachia molluscs are derived from a common biosynthetic 
pathway featuring a series of photochemically mediated 
rearrangements.38 Ireland and Scheuer further suggested that 
these strongly UV absorbing γ-pyrone natural products may 
serve an important biological function by acting as a 
sunscreen, protecting the molluscs from excessive UV 
exposure.39 
Building on this biosynthetic speculation, Moses and co-
workers proposed that this family of γ-pyrone natural products 
could be derived from a common polyene biosynthetic 
intermediate 41 (Scheme 7).40 Moses proposed that 
tridachiahydropyrone could be derived biosynthetically from 
polyene 41 through a 6π electrocyclisation. Depending on 
whether this electrocyclisation occurred in nature under 
thermal or photochemical conditions, a tridachiahydropyrone 
structure with a trans (disrotatory cyclization, structure 38a) or 
a cis (conrotatory cyclization, structure 38b) relationship 
between the C(9) and C(4) substituents would result. A 
previous total synthesis of the proposed structure of 
tridachiahydropyrone (38a) by Perkins and co-workers had 
indicated that the trans structure was incorrect.41 Therefore, in 
light of the postulated biological function of these compounds, 
Moses proposed the cis structure (38b), originating from a 
photochemical 6π electrocyclization, was likely to represent 
the correct structure of tridachiahydropyrone.40a Moses also 
suggested that the closely related natural products 
tridachiahydropyrones B (39a) and C (40a) were likely to be 
derived from tridachiahydropyrone (38b) via a [4+2] 
cycloaddition of singlet oxygen.40b 
 
Scheme 7. Moses’ proposed biosynthetic pathway for the 
tridachiahydropyrones. 
 
To test this biosynthetic hypothesis and proposed 
structural revision, Moses and co-workers undertook a 
biomimetic synthesis of the tridachiadhydropyrones (38b, 39a, 
40a).40 The key polyene 41 was prepared in 75% yield by a 
Suzuki coupling of the pyrone bromide 42 and diene boronic 
ester 43 (Scheme 8). Polyene 41 was then subjected to both 
thermal and photochemical conditions to test their 
biosynthetic hypothesis. Heating polyene 41 to 150°C 
produced no reaction; however, on exposure to sunlight for 
three days the desired tridachiahydropyrone 38b was formed 
in 29% yield, with all data matching that reported for the 
natural product (Scheme 8). NOESY and single crystal X-ray 
analysis of synthetic tridachiahydropyrone (38b) confirmed the 
anticipated cis stereochemistry, allowing Moses to confidently 
revise the structure of tridachiahydropyrone (38b) as well as 
lending support to the biosynthetic hypothesis.40a 
With samples of synthetic tridachiahydropyrone (38b) now 
available, Moses and co-workers were also able to test their 
biosynthetic hypothesis for tridachiahydropyrones B (39a) and 
C (40a). Exposure of tridachiahydropyrone (38b) to singlet 
oxygen gave quantitative conversion to a 4:5 mixture of two 
products, which matched the reported data for 
tridachiahydropyrones B and C. However, extensive nOe 
experiments on this mixture, supported by computational 
work on the possible product structures, indicated that only a 
single adduct is formed in the cycloaddition with singlet 
oxygen, with retention of the (E)-geometry at the C(10)−C(11) 
alkene (39b). The two products observed were, in fact, 
rotamers resulting from restricted rotation around the 
C(9)−C(10) bond. This observation was further confirmed 
through the use of variable temperature NMR experiments, 
allowing the reassignment of tridachiahydropyrones B and C as 
a single natural product 39b.40b 
 
Scheme 8. Total synthesis and structural reassignment of the 
tridachiahydropyrones. 
 
The success of this synthesis provides an excellent example 
of the broad range of benefits biosynthetic considerations can 
provide. Moses proposed a biosynthetic hypothesis, which 
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linked three natural products together, and by taking into 
account the possible sunscreen function of these compounds 
suggested a structural revision of tridachiahydropyrone (38b). 
By investigating this hypothesis synthetically they were able to 
validate this proposed structural revision and serendipitously 
reassign the structures of tridachiahydropyrones B (39a) and C 
(40a) as two rotamers of oxytridachiahydropyrone (39b).40 
3 Conclusions 
Despite the constantly improving power of modern 
spectroscopic techniques, paying thoughtful consideration to 
the biosynthetic origin of a natural product will continue to 
serve an invaluable role in natural product structure 
elucidation. Additionally, as our understanding of natural 
product function increases it is likely that functional 
considerations will play an ever-greater role in structure 
determination. 
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